CLPT logo

ClearPoint Neuro (CLPT) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$23.14 M
-$4.47 M-16.20%

31 December 2023

CLPT Cash And Cash Equivalents Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Cash And Cash Equivalents

$21.57 M
-$11.27 M-34.32%

30 September 2024

CLPT Quarterly Cash And Cash Equivalents Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CLPT Cash And Cash Equivalents Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-16.2%-11.4%
3 y3 years+15.1%-62.6%
5 y5 years+646.2%+246.0%

CLPT Cash And Cash Equivalents High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-57.2%+15.1%-62.6%+15.3%
5 y5 years-57.2%+646.2%-66.7%+278.7%
alltimeall time-57.2%>+9999.0%-66.7%>+9999.0%

ClearPoint Neuro Cash And Cash Equivalents History

DateAnnualQuarterly
Sept 2024
-
$21.57 M(-34.3%)
June 2024
-
$32.84 M(-7.1%)
Mar 2024
-
$35.35 M(+52.8%)
Dec 2023
$23.14 M(-16.2%)
$23.14 M(-4.9%)
Sept 2023
-
$24.34 M(-8.0%)
June 2023
-
$26.46 M(+21.4%)
Mar 2023
-
$21.79 M(-21.1%)
Dec 2022
$27.61 M(-49.0%)
$27.61 M(+47.6%)
Sept 2022
-
$18.71 M(-20.5%)
June 2022
-
$23.52 M(-52.6%)
Mar 2022
-
$49.66 M(-8.2%)
Dec 2021
$54.11 M(+169.2%)
$54.11 M(-6.1%)
Sept 2021
-
$57.65 M(-6.3%)
June 2021
-
$61.52 M(-5.1%)
Mar 2021
-
$64.86 M(+222.7%)
Dec 2020
$20.10 M(+252.9%)
$20.10 M(+37.0%)
Sept 2020
-
$14.67 M(-8.5%)
June 2020
-
$16.03 M(-5.6%)
Mar 2020
-
$16.98 M(+198.0%)
Dec 2019
$5.70 M(+83.7%)
$5.70 M(-8.6%)
Sept 2019
-
$6.24 M(-16.4%)
June 2019
-
$7.46 M(+199.5%)
Mar 2019
-
$2.49 M(-19.7%)
Dec 2018
$3.10 M
$3.10 M(-16.4%)
Sept 2018
-
$3.71 M(-44.6%)
DateAnnualQuarterly
June 2018
-
$6.70 M(-10.9%)
Mar 2018
-
$7.51 M(-19.1%)
Dec 2017
$9.29 M(+180.2%)
$9.29 M(-15.8%)
Sept 2017
-
$11.03 M(-13.4%)
June 2017
-
$12.74 M(+546.9%)
Mar 2017
-
$1.97 M(-40.6%)
Dec 2016
$3.32 M(-38.7%)
$3.32 M(-25.2%)
Sept 2016
-
$4.43 M(+119.9%)
June 2016
-
$2.02 M(-43.7%)
Mar 2016
-
$3.58 M(-33.8%)
Dec 2015
$5.41 M(-41.5%)
$5.41 M(+192.1%)
Sept 2015
-
$1.85 M(-47.4%)
June 2015
-
$3.52 M(-45.3%)
Mar 2015
-
$6.44 M(-30.4%)
Dec 2014
$9.24 M(+162.9%)
$9.24 M(+387.9%)
Sept 2014
-
$1.89 M(-53.5%)
June 2014
-
$4.08 M(-29.7%)
Mar 2014
-
$5.80 M(+65.0%)
Dec 2013
$3.52 M(+117.0%)
$3.52 M(-30.1%)
Sept 2013
-
$5.03 M(-27.9%)
June 2013
-
$6.98 M(-24.1%)
Mar 2013
-
$9.20 M(+467.8%)
Dec 2012
$1.62 M(+1013.4%)
$1.62 M(-57.2%)
Sept 2012
-
$3.79 M(+209.7%)
June 2012
-
$1.22 M(+740.5%)
Dec 2011
$145.50 K
$145.50 K

FAQ

  • What is ClearPoint Neuro annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for ClearPoint Neuro?
  • What is ClearPoint Neuro annual cash & cash equivalents year-on-year change?
  • What is ClearPoint Neuro quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for ClearPoint Neuro?
  • What is ClearPoint Neuro quarterly cash and cash equivalents year-on-year change?

What is ClearPoint Neuro annual cash & cash equivalents?

The current annual cash & cash equivalents of CLPT is $23.14 M

What is the all time high annual cash & cash equivalents for ClearPoint Neuro?

ClearPoint Neuro all-time high annual cash & cash equivalents is $54.11 M

What is ClearPoint Neuro annual cash & cash equivalents year-on-year change?

Over the past year, CLPT annual cash & cash equivalents has changed by -$4.47 M (-16.20%)

What is ClearPoint Neuro quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of CLPT is $21.57 M

What is the all time high quarterly cash and cash equivalents for ClearPoint Neuro?

ClearPoint Neuro all-time high quarterly cash and cash equivalents is $64.86 M

What is ClearPoint Neuro quarterly cash and cash equivalents year-on-year change?

Over the past year, CLPT quarterly cash and cash equivalents has changed by -$2.77 M (-11.38%)